TCD
Development of a proprietary vaccine platform technology, which can be administered nasally to generate more efficacious immunity and be longer lasting against bacterial driven infectious diseases, particularly respiratory infections, such as whooping cough . This novel vaccine development addresses an urgent global need for next-generation vaccine technologies.
Last Updated:
Last Updated:
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
